T-Therapeutics secured $133 million in an oversubscribed Series B funding round led by Advent Life Sciences and British Business Bank to develop its first-in-class TCR-CD3 bispecific therapies targeting cancer and autoimmune diseases. The funds will support clinical proof-of-concept studies for two lead programs leveraging the company’s proprietary OpTiMus® platform, which targets previously undruggable intracellular proteins. This advancement aims to address solid tumors and chronic inflammation with potential for broad therapeutic impact. The company also appointed Dr. Kirsty Crame as Chief Development Officer to guide clinical development, signaling a strategic move towards becoming a clinical-stage biotech firm.
T-Therapeutics announced an oversubscribed $133 million Series B financing round to advance clinical proof-of-concept for its novel TCR bispecific therapies in cancer and autoimmune diseases. For readers following the health sector, here is Pluang's market snapshot as of Nov 05, 2026 13:11 WIB: out of 150 priced US health stocks, 116 rose and 32 fell. Notable movers include MDLN at USD 40.35 with a 1-day change of +18.36%, ACHC at USD 34.05 up 14.96%, and ZBH at USD 110.15 gaining 13.49%.
UBS Group AG notified Bang & Olufsen A/S that its shareholding and voting rights exceeded 5% as of October 30, 2026, but fell below 5% by November 2, 2026. As of November 2, UBS held 4.66% of Bang & Olufsen's total shares and voting rights. This chan...
Siemens Healthineers has begun separating its in vitro diagnostics business into a standalone company named Olyrian Diagnostics, expected to complete by mid-2028. This move aims to give the diagnostics unit a distinct market presence while continuing...
IQM Quantum Computers reported a 52% increase in order backlog to €102.5 million by September 30, 2026, driven by major new contracts including the LUMI-IQ Halocene order. Q3 revenue rose 51% year-over-year to €8.9 million, with cash reserves at €260...
IQM Quantum Computers reported a 52% increase in order backlog to EUR 102.5 million by September 2026, driven by strong new orders including a EUR 33 million contract for its error-correction platform. Q3 revenue rose 51% year-over-year to EUR 8.9 mi...
Financial institutions are increasingly deploying multi-agent AI systems to enhance banking and insurance workflows, with 59% piloting or deploying such systems. However, only 10% have achieved full enterprise-wide orchestration, highlighting challen...
